A Look At Profitability And Quality Of For-Profit Day Care Centers

U sklopu ovog završnog rada analizira se model upravljanja letjelice s više rotora pomoću zakrilca. Taj je model prvenstveno razrađen za sustav dva rotora, odnosno za klackalicu, čije se projektiranje također obrađuje. Eksperimentalni rezultati dobiveni analizom projektirane klackalice koriste se za daljnje unaprijeđenje realnog modela letjelice s više rotora.This paper proposes the model of an aerial vehicle control based on movable surfaces (ailerons) designed for a two rotor system; an teeter. However, model of a four rotor vehicle is analysed as well. Experimental results obtained from teeter analysis can be used in order to further develop quadrotor aerial vehicle

Senior Recital: Lucas Gray, Baritone

This recital is presented in partial fulfillment of requirements for the degree Bachelor of Music in Music Education. Mr. Gray studies voice with Jana Young.https://digitalcommons.kennesaw.edu/musicprograms/2248/thumbnail.jp

Northern New England Clinical and Translational Research Network Assesses the Training Needs of Investigators

INTRODUCTION The Northern New England Clinical and Translational Research (NNE-CTR) Network was created to enhance the region’s research capacity and infrastructure. The NNE-CTR provides research design consultation and technical assistance, research technologies support, professional development opportunities and mentorship, as well as funding for pilot projects. This study sought to describe the characteristics of NNE-CTR investigators and to identify their research interests, training needs, and perceived barriers to research. METHODS A registration survey and 13-item needs assessment module were developed and administered to capture data on the characteristics, background, and research-related training needs, interests and barriers among investigators in Maine, New Hampshire and Vermont. Investigators were recruited via email, direct communication and the NNECTR website. Univariate statistics (frequency distributions and percentages) were calculated for all structured items. Bivariate frequencies were also generated to assess the relationship between training interests and level of research experience. Content analysis was performed on select open-ended items to identify common themes. RESULTS A total of 272 investigators participated. More than half of participants were women (60%), white (85%), and physicians (54%). A majority of respondents reported participating in a research project (88%) and indicated an interest in translational science research (51%), yet fewer than half reported receiving extramural funding. While lack of time and funding were identified as common barriers to research, many respondents expressed interest in receiving mentorship and/or pursuing training. A majority (54%) of participants were “very” interested in training related to study design. Participants with fewer than three years of research experience were more likely to report barriers related to lack of time to conduct research, while inadequate institutional support and challenges recruiting and identifying patients were more frequently reported by researchers with three or more years of experience. DISCUSSION The results revealed a range of research expertise and interests. Echoing findings from other similarly funded efforts, this study underscores the need to build core research skills through professional development. Yet, the study also demonstrates an opportunity to tailor training opportunities. CONCLUSIONS Ongoing efforts to match the identified needs and interests with the appropriate resources remains a key feature of the NNE-CTR

25 years of the WHO essential medicines lists: progress and challenges.

The first WHO essential drugs list, published in 1977, was described as a peaceful revolution in international public health. The list helped to establish the principle that some medicines were more useful than others and that essential medicines were often inaccessible to many populations. Since then, the essential medicines list (EML) has increased in size; defining an essential medicine has moved from an experience to an evidence-based process, including criteria such as public-health relevance, efficacy, safety, and cost-effectiveness. High priced medicines such as antiretrovirals are now included. Differences exist between the WHO model EML and national EMLs since countries face varying challenges relating to costs, drug effectiveness, morbidity patterns, and rationality of prescribing. Ensuring equitable access to and rational use of essential medicines has been promoted through WHO's revised drug strategy. This approach has required an engagement by WHO on issues such as the effect of international trade agreements on access to essential medicines and research and development to ensure availability of new essential medicines

High Temperature Electrochemical Engineering and Clean Energy Systems

Global power demand is projected to more than double by 2050 and meeting this increased power demand will require maintaining or increasing power output from all existing energy sources while adding a large amount of new capacity. The power sources that have the greatest opportunity to fulfill this demand gap over this time period are clean energy sources including solar and nuclear power. One of the areas of expertise that SRNL has been applying to help with a variety of clean energy technologies is in high temperature electrochemistry. Savannah River National Laboratory (SRNL) in collaboration with industrial and university partners has used high temperature electrochemical engineering to make improvements in solar power, nuclear fuel reprocessing, and fusion energy technologies. This article describes how high temperature electrochemistry has been applied at SRNL to mitigate corrosion in high temperature CSP systems, develop novel methods of nuclear fuel processing, and recover tritium in fusion energy technologies

Fall gardening

The Oklahoma Cooperative Extension Service periodically issues revisions to its publications. The most current edition is made available. For access to an earlier edition, if available for this title, please contact the Oklahoma State University Library Archives by email at [email protected] or by phone at 405-744-6311

The effect of the systemic inflammatory response on plasma vitamin 25 (OH) D concentrations adjusted for albumin

<b>Aim</b><p></p> To examine the relationship between plasma 25(OH)D, CRP and albumin concentrations in two patient cohorts.<p></p> <b>Methods</b><p></p> 5327 patients referred for nutritional assessment and 117 patients with critical illness were examined. Plasma 25 (OH) D concentrations were measured using standard methods. Intra and between assay imprecision was <10%.<p></p> <b>Result</b><p></p> In the large cohort, plasma 25 (OH) D was significantly associated with CRP (rs = −0.113, p<0.001) and albumin (rs = 0.192, p<0.001). 3711 patients had CRP concentrations ≤10 mg/L; with decreasing albumin concentrations ≥35, 25–34 and <25 g/l, median concentrations of 25 (OH) D were significantly lower from 35 to 28 to 14 nmol/l (p<0.001). This decrease was significant when albumin concentrations were reduced between 25–34 g/L (p<0.001) and when albumin <25 g/L (p<0.001). 1271 patients had CRP concentrations between 11–80 mg/L; with decreasing albumin concentrations ≥35, 25–34 and <25 g/l, median concentrations of 25 (OH) D were significantly lower from 31 to 24 to 19 nmol/l (p<0.001). This decrease was significant when albumin concentration were 25–34 g/L (p<0.001) and when albumin <25 g/L (p<0.001). 345 patients had CRP concentrations >80 mg/L; with decreasing albumin concentrations ≥35, 25–34 and <25 g/l, median concentrations of 25 (OH) D were not significantly altered varying from 19 to 23 to 23 nmol/l. Similar relationships were also obtained in the cohort of patients with critical illness.<p></p> <b>Conclusion</b><p></p> Plasma concentrations of 25(OH) D were independently associated with both CRP and albumin and consistent with the systemic inflammatory response as a major confounding factor in determining vitamin D status.<p></p&gt